More money better spent for immunisation is worthwhile but not every jab is equally cost efficient, and there are trade-offs with other valuable health and development activities Source: FT.com - Pharmaceuticals
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,